RT Journal Article
T1 Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.
A1 Llau, Juan V
A1 Ferrandis, Raquel
A1 Sierra, Pilar
A1 Gómez Luque, Aurelio
K1 stent thrombosis
K1 antiplatelet agents
K1 aspirin
K1 clopidogrel
K1 surgical bleeding
K1 perioperative management
K1 Pérdida de Sangre Quirúrgica
K1 Trombosis Coronaria
K1 Stents Liberadores de Fármacos
K1 Humanos
K1 Revascularización Miocárdica
K1 Atención Perioperativa
K1 Periodo Perioperatorio
K1 Piperazinas
K1 Inhibidores de Agregación Plaquetaria
K1 Tiofenos
K1 Ticlopidina
K1 Aspirina
AB The management of patients scheduled for surgery with a coronary stent, and receiving 1 or more antiplatelet drugs, has many controversies. The premature discontinuation of antiplatelet drugs substantially increases the risk of stent thrombosis (ST), myocardial infarction, and cardiac death, and surgery under an altered platelet function could also lead to an increased risk of bleeding in the perioperative period. Because of the conflict in the recommendations, this article reviews the current antiplatelet protocols after positioning a coronary stent, the evidence of increased risk of ST associated with the withdrawal of antiplatelet drugs and increased bleeding risk associated with its maintenance, the different perioperative antiplatelet protocols when patients are scheduled for surgery or need an urgent operation, and the therapeutic options if excessive bleeding occurs.
PB Dove Medical Press. Auckland
SN 1176-6344
YR 2010
FD 2010
LK http://hdl.handle.net/10668/819
UL http://hdl.handle.net/10668/819
LA en
NO Llau JV, Ferrandis R, Sierra P, Gómez-Luque A. Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update. Vasc Health Risk Manag; 6:855-67
NO Journal Article; Review;
DS RISalud
RD Apr 12, 2025